Customer Center

Samyang News

Samyang News
Samyang Biopharmaceuticals Corp. Attends, ‘Arab Health 2018’ Print
Affiliates Samyang Biopharm Writer administrator Hits 3161 Date 2018.01.29

Samyang Biopharmaceuticals Corporation attended ‘Arab Health 2018’, the 43rd international healthcare exhibition held in Dubai from January 29 to February 1, 2018.

 

At this exhibition Samyang Biopharmaceuticals Corporation showcased its wound care products, highlighting the superiority of the suture products such as Trisorb, Neosorb, Monosorb, Monofast, and Antibacterial sutures, as well as ORC styptic products such as Surgi-Guard.

 

Samyang Biopharmaceuticals Corporation networked with over 30 overseas clients at the ‘Arab Health 2018’ and shared their thoughts on business for the year 2018.

이전 다음글 제목을 나타낸 표
Prev Samyang Biopharmaceutical Corp. ‘s Genexol ® 2018.03.14
Next Samyang Corporation concludes Technology Transfer Agreement of Oxime Photoinitiator with the Korea Research Institute of Chemical Technology 2018.01.23